Increasing evidence shows that the loss or inactivation of the SMAD4 gene, a critical mediator of the transforming growth factor beta (TGF-β) signaling pathways, indicates a poor prognosis in various cancers, especially pancreatic cancer [47]. The gene discussed is TGFB1; the disease is cancer.